Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Clinical trial NCT04641143 · COMPLETED
Trial details
- NCT number
- NCT04641143
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2025-10-27
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.